Literature DB >> 403146

An immunological enhancement phenomenon in experimental brucella infection of the chicks.

A Forget, A G Borduas.   

Abstract

The passive transfer of chicken anti-brucella immune globulins promote the survival of Brucella abortus in the spleen of chickens infected with this bacteria. This enhancing effect was reduced significantly when the immune globulins were absorbed with heat-killed brucella cells to remove all the anti-brucella agglutinins and immune adherence antibodies. Therefore, it is most probable that the enhancing effect is related to the presence of brucella antibodies.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 403146     DOI： 10.1159/000231751

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN： 0020-5915


  5 in total

1.  Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies.

Authors:  R A Margni; G Perdigón; C Abatángelo; T Gentile; R A Binaghi
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

2.  Agglutinating and non-agglutinating antibodies in rabbits inoculated with a particulate antigen (Salmonella typhimurium).

Authors:  R A Margni; E A Parma; S Cerone; A Erpelding; G Perdigón
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

3.  Human anti-tetanus toxin precipitating and co-precipitating antibodies.

Authors:  G Perdigón; R A Margni; T Gentile; C Abatángelo; J Dokmetjian
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

4.  Interaction of purified precipitating and non-precipitating (coprecipitating) antibodies with hapten and with haptenated protein. Evidence of an asymmetric antibody molecule.

Authors:  J R Ronco; E Sciutto; J Leoni; R A Margni; R A Binaghi
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

5.  Killing of Brucella abortus by bovine serum.

Authors:  L B Corbeil; K Blau; T J Inzana; K H Nielsen; R H Jacobson; R R Corbeil; A J Winter
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.